Proprietary dual-vector platform delivers full-length ABCA4, enabled by Atsena's laterally spreading AAV.SPR capsid for delivery to the central ...
Scientists at the University of Illinois Chicago have turned an unlikely source into a potential new weapon against cancer: ...
A Korean research team has developed a new viral vector technology that significantly improves the production efficiency of next-generation cell and gene therapies known as CAR immune cell therapies, ...
Researchers at the University of Bayreuth and Forschungszentrum Jülich have demonstrated that specific light-sensitive ...
As cell therapies scale, developers face a choice: redesign processes for all-in-one systems or manage complex bespoke ...
Parkinson’s disease affects more males than females and they tend to have a higher risk. A new study in brain cells sheds ...
Explore how space oncology could transform cancer treatment through microgravity research and innovative drug development ...
Alzheimer's disease (AD) is a devastating neurodegenerative disorder heavily characterized by amyloid-beta (Aβ) plaques, ...
Genetic engineering could be used to develop new, more effective production systems for viral vector producing cell lines.
Financing co-led by GordonMD Global Investments® LP and M VenturesCompany rebrands from EG 427 to Cyllene Therapeutics Paris, July 07, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results